Patient’s Perception of Nigerian Physiotherapists as Supplementary Prescribers
American Journal of Health Research
Volume 2, Issue 5-1, October 2014, Pages: 6-11
Received: Sep. 2, 2014; Accepted: Sep. 19, 2014; Published: Sep. 27, 2014
Views 3279      Downloads 96
Authors
Onigbinde Ayodele Teslim, Department of Medical Rehabilitation, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
Oyedemi Oluwapelumi Jeremiah, Department of Medical Rehabilitation, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
Tarimo Nesto, Department of Physiotherapy, Malawi Against Physical disabilities, P. O. Box 256, Blantyre, Malawi
Mukoka Grace, Physiotherapy department, Department of Physiotherapy, College of Medicine, University of Malawi, Blantyre, Malawi
Article Tools
Follow on us
Abstract
In supplementary prescription (SP) of drugs; patient must consent and ascent to clinical management plans (CMP) and this is the principle of shared decision making (SDM). Shared decision making is a modern care ideology being used to promote effective treatment of patients. If physiotherapists are to become supplementary prescribers (SPs) it is important to seek patient’s opinion as they are also expected to be involved in drawing the CMP. The primary aim of this study was to investigate the opinion of Nigerian patients on enlistment and legislation of physiotherapists as supplementary prescribers. A structured and self-administered questionnaire was used to seek the opinion of 240 patients. They were selected from purposively selected health institutions in Nigeria. The data were analyzed using descriptive statistics of frequency, percentage and non-parametric inferential statistics (chi-square). A significant number of patients opined that prescription of drugs should not be restricted to medical doctors alone (X2 =193.67, P<0.001). One hundred and ninety four (81.17%) participants supported the enactment of policies that will recognize physiotherapists as SPs. Similarly, a significant number of patients opined that physiotherapist should only prescribe oral drugs at the chronic stage of diseases (X2 =35.53, P<0.001). Majority opined that supplementary prescribing will reduce waiting time in hospital (92.89%), reduce burden on medical doctors (94.48%); and increase accessibility and timely intervention of medical care (94.15%). In conclusion, most patients opined that Nigeria physiotherapists should be allowed to become supplementary prescribers of relevant oral drugs because of the enormous benefits to patient care. Also, an enactment should be made to protect them against litigations.
Keywords
Supplementary Prescription, Patients, Physiotherapists, Medications, Enlistment
To cite this article
Onigbinde Ayodele Teslim, Oyedemi Oluwapelumi Jeremiah, Tarimo Nesto, Mukoka Grace, Patient’s Perception of Nigerian Physiotherapists as Supplementary Prescribers, American Journal of Health Research. Special Issue: Supplementary Prescribing in Nigeria: A Needy Concept to Promote Clinical Physiotherapy Practice. Vol. 2, No. 5-1, 2014, pp. 6-11. doi: 10.11648/j.ajhr.s.2014020501.12
References
[1]
Borthwick Alan M, Anthony J Short, Susan A Nancarrow, Rosalie Boyce (2010). Non- medical prescribing in Australasia and the UK: the case of podiatry. J Foot Ankle Res. 2010; 3: 1.
[2]
Royal Australian College of General Practitioner (RACGP). The RACGP Curriculum for Australian General Practice. Multidisciplinary care (2011). http://curriculum. racgp.org.au/statements/multidisciplinary-care/. Accessed on 20th June 2014.
[3]
Crown report (1999). Review of prescribing, supply & administration of medicines. Final Report April 2000 Secretary of State for Health Room 407, Richmond House 79 Whitehall London SW1A 2NS. http://webarchive.nationalarchives.gov.uk/ 2013010 7105 354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4077153.pdf. Accessed on 18th June 2014.
[4]
Brown JB, Stewart MA, McCracken E, et al (1986). The patient-centred clinical method, 2: definition and application. Fam Pract. 1986;3:75
[5]
National Health Services (2010). A safe prescription: Developing nurse, midwife and allied health profession (NMAHP) prescribing in Scotland. http://www. nes.scot.nhs. uk/media/555947/a_safe_prescription_progress_report_2010.pdf. Accessed on 20th June 2014.
[6]
National Treatment Agency for Substance Misuse (2007). Non-medical prescribing, patient group directions and minor ailment schemes in the treatment of drug misusers. www.nta.nhs.uk. Accessed on 18th June 2014.
[7]
Health Sciences (2014). Our role in the non-medical prescribing revolution. University of Southampton.http://www.southampton.ac.uk/healthsciences/businesspartnership/services/ nonmedicalprescribing. Accessed on 20th June 2014.
[8]
Safran DG, Taira DA, Rogers WH, et al (1998): Linking primary care performance to outcomes of care. J Fam Pract. 1998; 47: 213–220.
[9]
Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA (2002). "The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management". J Gen Intern Med 17 (4): 243–52.
[10]
Hibbard JH, Mahoney ER, Stock R, Tusler M (2007). Do increases in patient activation result in improved self-management behaviors. Health Serv Res 42 (4): 1443–63. doi:10.1111/j.1475-6773.2006.00669.x. PMC 1955271. PMID 17610432.
[11]
Lewin SA, Skea ZC, Entwistle V, Zwarenstein M, Dick J (2002): Interventions for providers to promote a patient-centred approach in clinical consultations. (Cochrane Review). In: The Cochrane Library, Issue 1. Oxford: Update Software. Available at: http://www.mrc.ac.za/policybriefs/1polbrief2002.htm [Accessed 10 May 2014].
[12]
Höglund AT, Winblad U, Arnetz B, Arnetz JE (2010). "Patient participation during hospitalization for myocardial infarction: perceptions among patients and personnel". Scand J Caring Sci 24 (3): 482–9. doi:10.1111/j.1471-6712.2009.00738.x. PMID 20230518.
[13]
Julia M. Hush, Kirsten Cameron and Martin Mackey Therapy Care (2010): A Systematic Review Patient Satisfaction with Musculoskeletal Physical November 11, 2010 Phys Ther. 2011; 91:25-36.
[14]
Salisbury and Sullivan (1998). Clinical decision making planning effective treatments. In O'Sullivan SB, Schmitz TJ (eds). Pkysical Rehabilitation Assessment and Treatment, 4th ed. Philadelphia, PA, Davis, 2001, pp 1-7.
[15]
Health and Care Professions Council (2014). Post-registration programmes. Approval visit reports.http://www.hpc-uk.org/education/programmes/approval reports/index.asp ?id=688&ep=64
[16]
Onigbinde Ayodele, Solomon S. Adereni Adebiyi, Kayode D.S. Bamitale, S.V.K. Kambalametore, Vyvienne M’kumbuzi, Wazakili Margaret (2013). Changing the prescription status of physiotherapy. Nigeria journal of Medical Rehabilitation, Vol. 16, No 2. Available at http://www.njmr.org.ng. Accessed on 17 June 2014.
[17]
17] Ojo Ayodele Mojisola (2014). Opinion of pharmacists on the enlistment of physiotherapists as supplementary prescribers of relevant medications. An unpublished dissertation of the department of Medical Rehabilitation department of Obafemi Awolowo University, Ile-lfe, Osun State, Nigeria.
[18]
Onigbinde AT, Olaogun MOB, Irogue K (2012). An evaluation of the knowledge level of Nigerian Physiotherapists on topical pharmacotherapy Hong Kong Physiotherapy Journal, Vol. 1 Pgs 1-7.
[19]
Department of Health, Social Services and Public Safety (DHSSPS) (2004). Best Practice Guidance for Supplementary Prescribing by Nurses within the HPSS in Northern Ireland DHSSPS.
[20]
Mathers Nigel, Nick Fox, Amanda Hunn (2009). Surveys and Questionnaires. The NIHR Research Design Service for Yorkshire & the Humber. www.rds-eastmidlands.nihr.ac.uk
[21]
García de Yébenes Prous M. Jesús, Francisco Rodríguez Salvanés, Loreto Carmona Ortells (2009). Validation of questionnaires. Reumatol Clin. 2009;5 (4):171-177.
[22]
Bissell Paul, Richard Cooper, Louise Guillaume, Claire Anderson, Anthony Avery, Allen Hutchinson, Veronica James (2008): An Evaluation of Supplementary Prescribing in Nursing and Pharmacy Final Report for the Department of Health October 2008. http://eprints.whiterose.ac.uk/76239/1/Supplementary_prescribing.pdf. Accessed on 19th June 2014.
[23]
Cooper. Richard J, Paul Bissell, Paul Ward, Elizabeth Murphy, Claire Anderson, Tony Avery, Veronica James (2011). Further challenges to medical dominance? The case of nurse and pharmacist supplementary prescribing. University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK. Email: richard.cooper@sheffield.ac.uk
[24]
Borthwick A (2001). Drug prescribing in podiatry: Radicalism or Tokenism?Brit J Podiatr. 4: 56–64.
[25]
Department of Health (2005). Supplementary Prescribing by Nurses, Pharmacists, Chiropodists/Podiatrists, Physiotherapists and Radiographers within the NHS in England: A guide for implementation Available at: http://webarchive.nationalarchives.gov.uk/ 20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4110033.pdf. Accessed 25 November, 2013.
[26]
Stephensons Terence (2000). Implications of the Crown’s report and nurse prescribing. Arch Dis Child, (6)83: 199 - 202
[27]
Royal college of nursing (2012). RCN Fact Sheet. Nurse Prescribing in the UK. Policy and International Department. http://www.rcn.org.uk/__data/assets/pdf_/Nurse_ Prescribing_in_the_UK_-_RCN_ Factsheet.pdf. Accessed 25 November, 2013.
[28]
Scottish Executive Health Department (2003). Scottish Executive Health Department (2003): Supplementary Prescribing by Nurses within NHS Scotland © Crown copyright 2003
[29]
Non-medical prescribing center (2005). Improving mental health services by extending the role of nurses in prescribing and supplying medication: Good Practice Guide. London: National Prescribing Centre, National Institute of Mental Health, Department of Health.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186